Holen Sie sich die Stockscreener-App
20.58
1.06%
-0.22
Handel nachbörslich:
20.58
Schlusskurs vom Vortag:
$20.80
Offen:
$20.78
24-Stunden-Volumen:
861.70K
Relative Volume:
0.97
Marktkapitalisierung:
$1.06B
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-7.6506
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
+1.88%
1M Leistung:
+5.65%
6M Leistung:
+60.91%
1J Leistung:
-8.74%
1-Tages-Spanne:
$20.35
$21.20
1-Wochen-Bereich:
$19.90
$21.48
52-Wochen-Spanne:
$10.96
$25.55
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
20.58 | 1.07B | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
623.91 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.75 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
694.75 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.04 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.95 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance Singapore
Can CareDx Inc deliver consistent dividendsDollar Strength & Advanced Swing Trade Entry Alerts - mfd.ru
Death Cross: Is CareDx Inc a play on infrastructure spendingCPI Data & AI Based Buy and Sell Signals - baoquankhu1.vn
CareDx CEO Hanna sells $412,222 in shares By Investing.com - Investing.com Nigeria
CareDx CEO Hanna sells $412,222 in shares - Investing.com
Insider Sell: Hanna John Walter JR Sells Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 19,280 Shares - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator With 4.66% Upside Potential - directorstalkinterviews.com
CareDx (NASDAQ:CDNA) CEO John Walter Hanna Jr Sells 10,156 Shares - MarketBeat
Tech Rally: What is the dividend yield of CareDx IncJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
Sentiment Review: Can CareDx Inc generate free cash flow2025 Winners & Losers & Community Verified Trade Alerts - baoquankhu1.vn
Sumitomo Mitsui Trust Group Inc. Raises Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
CareDx (CDNA) Is Up 19.5% After Stronger-Than-Expected 2025 Revenue GuidanceHas The Bull Case Changed? - Sahm
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
CareDx (CDNA) Valuation Check After Strong Preliminary 2025 Revenue Guidance And Transplant+ Pipeline Progress - Sahm
Can CareDx Inc maintain sales growthJuly 2025 Short Interest & Expert Curated Trade Setups - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and CareDx (CDNA) - The Globe and Mail
Implied Volatility Surging for CareDx Stock Options - sharewise.com
Aug Levels: Is AEYE stock forming a triangle patternRate Hike & Precise Entry and Exit Recommendations - baoquankhu1.vn
CareDx (CDNA) Is Up 9.4% After Strong 2025 Outlook And 10x Genomics Tie-UpHas The Bull Case Changed? - Yahoo Finance
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 - Investing.com Canada
CareDx (NASDAQ:CDNA) Trading 15.3% HigherTime to Buy? - MarketBeat
Caredx Provides Earnings Guidance Fourth Quarter and Full Year 2025 - marketscreener.com
Aug Wrap: Is CareDx Inc a play on infrastructure spendingStop Loss & Weekly High Return Stock Forecasts - baoquankhu1.vn
CareDx Preliminary Q4 Revenue Up 25% - Nasdaq
CareDx reports 25% revenue growth in Q4, expects $380 million for 2025 By Investing.com - Investing.com South Africa
CareDx's prelim Q4 revenue beats estimates on higher testing volumes - TradingView — Track All Markets
Transplant test maker CareDx reports 25% jump in late‑2025 revenue - Stock Titan
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Joplin Globe
Whittier Daily News - FinancialContent
Profit Review: Can CareDx Inc stock continue upward trendJuly 2025 PostEarnings & Low Risk High Reward Ideas - moha.gov.vn
Why CareDx Inc stock is popular among millennialsGap Down & Verified Chart Pattern Signals - Улправда
Aug Opening: Can CareDx Inc stock continue upward trendJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда
Can CareDx Inc stock hit record highs again2025 Earnings Surprises & Daily Stock Momentum Reports - Улправда
Dow Update: Will CareDx Inc (1K9) stock gain from lower interest ratesJuly 2025 Macro Moves & AI Enhanced Trading Alerts - Улправда
Why retail investors pile into CareDx Inc stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - Улправда
Why CareDx Inc stock is in analyst buy zoneMarket Activity Summary & Verified Momentum Stock Ideas - ulpravda.ru
CareDx (NASDAQ:CDNA) Trading Down 7.9%What's Next? - MarketBeat
Can CareDx Inc stock continue upward trendShare Buyback & Entry Point Strategy Guides - ulpravda.ru
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
CareDx (CDNA) director Michael Goldberg receives 1,492-share equity grant - Stock Titan
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - Sahm
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - marketscreener.com
CareDx and 10x Genomics partner on transplant rejection research - Investing.com
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - marketscreener.com
User - FinancialContent
CareDx wins preliminary court approval for derivative settlement - MSN
CareDx (NASDAQ:CDNA) Shares Gap DownHere's Why - MarketBeat
Craig-Hallum downgrades CareDx stock rating to Hold from Buy By Investing.com - Investing.com South Africa
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):